These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29173108)
1. Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising. Kiernicki K; Helme DW Health Mark Q; 2017; 34(4):284-301. PubMed ID: 29173108 [TBL] [Abstract][Full Text] [Related]
2. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746 [TBL] [Abstract][Full Text] [Related]
3. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study. Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements. Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947 [No Abstract] [Full Text] [Related]
5. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall. O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471 [TBL] [Abstract][Full Text] [Related]
6. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements. Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621 [TBL] [Abstract][Full Text] [Related]
7. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model. Ju I; Park JS Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136 [TBL] [Abstract][Full Text] [Related]
8. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement. Lemanski JL; Villegas J Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298 [TBL] [Abstract][Full Text] [Related]
9. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Adams C J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749 [TBL] [Abstract][Full Text] [Related]
10. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising. Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071 [TBL] [Abstract][Full Text] [Related]
11. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach. Bhutada NS; Rollins BL; Perri M Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337 [TBL] [Abstract][Full Text] [Related]
12. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine. Park JS; Ahn HA; Haley EJ Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885 [TBL] [Abstract][Full Text] [Related]
13. Enhancing the educational value of direct-to-consumer advertising of prescription drugs. Hwang MJ; Young HN J Am Pharm Assoc (2003); 2017; 57(5):571-578. PubMed ID: 28676435 [TBL] [Abstract][Full Text] [Related]
14. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016. Liu J; Avery RJ; Kim JJ; Niederdeppe J J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131 [TBL] [Abstract][Full Text] [Related]
15. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069 [TBL] [Abstract][Full Text] [Related]
16. Visual images of prescription drug benefits in direct-to-consumer television advertisements. Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970 [TBL] [Abstract][Full Text] [Related]
17. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements. Wogalter MS; Shaver EF; Kalsher MJ Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979 [TBL] [Abstract][Full Text] [Related]
18. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising. Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655 [TBL] [Abstract][Full Text] [Related]
19. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines. Klara K; Kim J; Ross JS J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575 [TBL] [Abstract][Full Text] [Related]
20. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising. Jiang P Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]